Secondary Outcome(s)
|
Secondary Outcome Will be the Unified Multiple System Atrophy Rating Scale (UMSARS). Statistical Analysis Will be Performed to Compare the Effect of Treatment on Both Groups.
[Time Frame: 24 weeks]
|
Micro- and Macrostructural Magnetic Resonance Parameters Will be Compared Before and After Treatment. This Will Include Voxel Based Morphometry, Resting Functional MRI, Diffusion Tensor Imaging and MRI Spectroscopy.
[Time Frame: 48 weeks]
|
Secondary Outcome Will be the Unified Multiple System Atrophy Rating Scale (UMSARS). Statistical Analysis Will be Performed to Compare the Effect of Treatment on Both Groups.
[Time Frame: 48 weeks]
|
Effect of Lithium on Quality of Life Will be Assessed With the EQ-5D Scale.
[Time Frame: 24 weeks]
|
The Effect of Lithium on Mood Will be Explored With the Beck Depression Inventory.
[Time Frame: 0 weeks]
|
Effect of Lithium on Quality of Life Will be Assessed With the EQ-5D Scale.
[Time Frame: 48 weeks]
|
Micro- and Macrostructural Magnetic Resonance Parameters Will be Compared Before and After Treatment. This Will Include Voxel Based Morphometry, Resting Functional MRI, Diffusion Tensor Imaging and MRI Spectroscopy.
[Time Frame: 0 weeks]
|
Effect of Lithium on Quality of Life Will be Assessed With the EQ-5D Scale.
[Time Frame: 0 weeks]
|
The Effect of Lithium on Mood Will be Explored With the Beck Depression Inventory.
[Time Frame: 48 weeks]
|
The Effect of Lithium on Mood Will be Explored With the Beck Depression Inventory.
[Time Frame: 24 weeks]
|
Secondary Outcome Will be the Unified Multiple System Atrophy Rating Scale (UMSARS). Statistical Analysis Will be Performed to Compare the Effect of Treatment on Both Groups.
[Time Frame: 0 weeks]
|